Liquidia Corp (LQDA)
12.79
-0.19
(-1.46%)
USD |
NASDAQ |
May 03, 16:00
12.78
0.00 (0.00%)
After-Hours: 20:00
Liquidia Total Return Level: 12.79 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 12.79 |
May 02, 2024 | 12.98 |
May 01, 2024 | 13.17 |
April 30, 2024 | 12.85 |
April 29, 2024 | 12.46 |
April 26, 2024 | 12.53 |
April 25, 2024 | 12.37 |
April 24, 2024 | 12.55 |
April 23, 2024 | 12.95 |
April 22, 2024 | 13.18 |
April 19, 2024 | 13.29 |
April 18, 2024 | 13.81 |
April 17, 2024 | 13.86 |
April 16, 2024 | 13.58 |
April 15, 2024 | 13.68 |
April 12, 2024 | 13.95 |
April 11, 2024 | 15.33 |
April 10, 2024 | 14.83 |
April 09, 2024 | 14.96 |
April 08, 2024 | 15.13 |
April 05, 2024 | 15.71 |
April 04, 2024 | 15.30 |
April 03, 2024 | 15.35 |
April 02, 2024 | 15.38 |
April 01, 2024 | 14.92 |
Date | Value |
---|---|
March 28, 2024 | 14.75 |
March 27, 2024 | 15.07 |
March 26, 2024 | 15.92 |
March 25, 2024 | 15.67 |
March 22, 2024 | 16.73 |
March 21, 2024 | 16.24 |
March 20, 2024 | 15.90 |
March 19, 2024 | 16.02 |
March 18, 2024 | 15.56 |
March 15, 2024 | 15.90 |
March 14, 2024 | 15.32 |
March 13, 2024 | 14.73 |
March 12, 2024 | 13.98 |
March 11, 2024 | 13.61 |
March 08, 2024 | 14.04 |
March 07, 2024 | 13.66 |
March 06, 2024 | 13.63 |
March 05, 2024 | 13.79 |
March 04, 2024 | 13.69 |
March 01, 2024 | 14.52 |
February 29, 2024 | 14.16 |
February 28, 2024 | 14.38 |
February 27, 2024 | 14.69 |
February 26, 2024 | 14.62 |
February 23, 2024 | 14.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.28
Minimum
Aug 04 2021
16.73
Maximum
Mar 22 2024
6.018
Average
5.61
Median
Aug 19 2020
Total Return Level Benchmarks
United Therapeutics Corp | 262.40 |
AIM ImmunoTech Inc | 0.4048 |
Perspective Therapeutics Inc | 1.81 |
Protalix BioTherapeutics Inc | 1.14 |
Armata Pharmaceuticals Inc | 2.49 |